Richard A. Edlin - Sep 6, 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Director
Signature
/s/ Scott Tarriff, Attorney-in-Fact
Stock symbol
EGRX
Transactions as of
Sep 6, 2022
Transactions value $
-$210,732
Form type
4
Date filed
9/8/2022, 05:08 PM
Previous filing
Mar 2, 2022
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Sale -$211K -6.8K -23.13% $30.99 22.6K Sep 6, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.